Nicolai Lagoni is a partner in the German Corporate Group with deep experience in the fields of M&A, joint ventures and corporate law. His clients are multinational corporations and investors, which he regularly advises on complex cross-border transactions.
Nicolai has wide-ranging experience in the areas of technology, real estate and pharmaceuticals & life sciences.
Prior to joining the firm, Nicolai worked for several years in the German Corporate/M&A Groups of Hengeler Mueller and Olswang. In 2009 he was seconded to an international pharmaceutical company.
Concentrations
•Private & public M&A
•Private equity
•Joint ventures
•Corporate law
•Capital markets
Recognition & Leadership
Awards & Accolades
•Listed, Chambers Global, 'Corporate/M&A: Mid-Market - Germany,' 2022-2025
•Listed, Chambers Germany, 'Corporate/M&A: Mid-Market,' 2025
•Listed, Chambers Europe, 'Corporate/M&A: Mid-Market - Germany,' 2022-2024
•Listed, EMEA Legal 500, 'Corporate M&A - M&A' and 'Private Equity - Transactions,' 2024-2025, 'Private Equity - Venture Capital,' 2025
•Listed, IFLR1000, 'Notable Practitioner,' M&A, 2019-2025
•JUVE Handbook 2018/2019: 'frequently recommended' for corporate law: 'creative person, thinks strategically', competitors describe him as 'highly skilled and structured'
•Recommended by Handelsblatt/Best Lawyers in Germany 2018/2019 for M&A
•Team Member, Chambers USA Award for Excellence, Real Estate, 2017
•Listed by The Legal 500 for M&A/Transactions
•Listed by IFLR1000 for M&A in Pharmaceuticals in Life Sciences, Real Estate and Technology & telecommunications
•Scholar of the International Max Planck Research School Maritime Affairs